Yun Ling

Active 1996–2026

261
Papers
21,706
Citations
71
h-index
189
i10-index

Citations

Citations per year for Yun Ling1971: 1 citations1988: 1 citations1991: 1 citations2004: 1 citations2005: 1 citations2006: 1 citations2007: 7 citations2008: 15 citations2009: 10 citations2010: 16 citations2011: 23 citations2012: 35 citations2013: 48 citations2014: 78 citations2015: 133 citations2016: 118 citations2017: 110 citations2018: 152 citations2019: 314 citations2020: 2,312 citations2021: 1,723 citations2022: 1,055 citations2023: 743 citations2024: 1,025 citations2025: 531 citations2026: 51 citations1972–1987: no citations, so these years are not shown1989–1990: no citations, so these years are not shown1992–2003: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,782 citing papers, 21.6% of this breakdownUnited States: 2,112 citing papers, 16.4% of this breakdownUnited Kingdom: 653 citing papers, 5.1% of this breakdownIndia: 525 citing papers, 4.1% of this breakdownItaly: 496 citing papers, 3.8% of this breakdownGermany: 433 citing papers, 3.4% of this breakdownFrance: 404 citing papers, 3.1% of this breakdownAustralia: 363 citing papers, 2.8% of this breakdownCanada: 347 citing papers, 2.7% of this breakdownSpain: 264 citing papers, 2% of this breakdownIran: 254 citing papers, 2% of this breakdownSouth Korea: 247 citing papers, 1.9% of this breakdown
0%21.6%Other 31.1%

Fields

  • Medicine55.8%
  • Biochemistry, Genetics and Molecular Biology11.9%
  • Computer Science10.6%
  • Engineering5.8%
  • Immunology and Microbiology5.6%
  • Neuroscience1.5%
  • Other8.8%

Topics

  • COVID-19 Clinical Research Studies11.3%
  • SARS-CoV-2 and COVID-19 Research7.2%
  • Long-Term Effects of COVID-195.1%
  • SARS-CoV-2 detection and testing1.9%
  • COVID-19 diagnosis using AI1.6%
  • COVID-19 and healthcare impacts1.3%
  • Other71.6%

Coauthors

All papers

Open in search
  1. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Lin, Jun Lin, Yun Ling, Jianwei Liu, Jianwei Liu, Nianping Liu, Shu-Qiang Liu, Meng Luo, Qiang Ma, Qibing Song, Wujianan Sun, Feng Wang, Feng Wang, Feng Wang, Ying Wang, Xiaofeng Wen, Qian Wu, Gang Xu, Xudong Xing, Xinxin Xiong, Xudong Xing, Dongdong Yu, Chonghai Yin, Dongdong Yu, Kezhuo Yu, Jin Yuan, Biao Zhang, Peipei Zhang, Tong Zhang, Jincun Zhao, Peidong Zhao, Peidong Zhao, Jianfeng Zhou, Wei Zhou, Sujuan Zhong, Xiaosong Zhong, Shuye Zhang, Jiahua Zou, Ping Zhu, Bin Zou, Jiahua Zou, Zengtao Zuo, Fan Bai, Xi Huang, Penghui Zhou, Qinghua Jiang, Zhiwei Huang, Jin‐Xin Bei, Lai Wei, Xiu‐Wu Bian, Xindong Liu, Tao Cheng, Xiangpan Li, Pingsen Zhao, Pingsen Zhao, Fu‐Sheng Wang, Xiaoqun Wang, Hongyang Wang, Bing Su, Bing Su, Zheng Zhang, Kun Qu, Xiaoqun Wang, Jiekai Chen, Ronghua Jin, Zemin Zhang - Cell 2021 cited by 947

  2. End-to-end deep learning approach for Parkinson’s disease detection from speech signals

    Authors: , , , , - Journal of Applied Biomedicine 2022 cited by 125

  3. Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 281

  4. Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 156

  5. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tamar Rubin, Melike Emiroğlu, Nima Parvaneh, Daniel Eriksson, Maribel Aranda‐Guillén, David I. Berrios, Linda Vong, Constance H. Katelaris, Peter Mustillo, Johannes Raedler, Jonathan Bohlen, Jale Bengi Çelik, Camila Astudillo, Sarah Winter, Stéphanie Boisson‐Dupuis, Éric Oksenhendler, Satoshi Okada, Oana Caluseriu, Mathilde Valeria Ursini, Éric Ballot, Geoffroy Lafarge, Tomáš Freiberger, Carlos A. Arango-Franco, Romain Lévy, COVID Human Genetic Effort, Alessandro Aiuti, Saleh Al‐Muhsen, Fahd Al‐Mulla, Evangelos Andreakos, Andrés A. Arias, Hagit Baris Feldman, Paul Bastard, Анастасія Бондаренко, A. Borghesi, Ahmed Aziz Bousfiha, Petter Brodin, Yenan T. Bryceson, Giorgio Casari, John Christodoulou, Roger Colobrán, Antonio Condino-Neto, Jacques Fellay, Carlos Flores, José Luis Franco, Filomeen Haerynck, Rabih Halwani, Lennart Hammarström, James R. Heath, Elena W.Y. Hsieh, Yuval Itan, Elżbieta Kaja, Kai Kisand, Cheng‐Lung Ku, Yun Ling, YL Lau, Davood Mansouri, Isabelle Meyts, Joshua D. Milner, Trine H. Mogensen, Antonio Novelli, Giuseppe Novelli, Keisuke Okamoto, Tayfun Özçelık, Rebeca Pérez de Diego, Jordi Pérez‐Tur, David S. Perlin, Carolina Prando, Aurora Pujol, Lluís Quintana‐Murci, Laurent Rénia and 126 more - Nature 2023 cited by 105

  6. Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jie Wang, Jie He - Journal of Thoracic Oncology 2020 cited by 415

  7. Autoantibodies against type I IFNs in patients with critical influenza pneumonia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anastasiia Bondarenko, Ahmed Aziz Bousfiha, Petter Brodin, Yenan T. Bryceson, Carlos D. Bustamante, Manish J. Butte, Giorgio Casari, John Christodoulou, Antonio Condino-Neto, Stefan N. Constantinescu, Megan A. Cooper, Clifton L. Dalgard, Murkesh Desai, Beth A. Drolet, Jamila El Baghdadi, Sara Elva Espinosa‐Padilla, Jacques Fellay, Carlos Flores, Paraskevi C. Fragkou, José Luis Barrera Franco, Antoine Froidure, Ioanna E. Galani, Peter K. Gregersen, Bodo Grimbacher, Filomeen Haerynck, David Hagin, Rabih Halwani, Lennart Hammarström, James R. Heath, Sarah E. Henrickson, Elena W.Y. Hsieh, Eystein Husebye, Kohsuke Imai, Yuval Itan, Erich D. Jarvis, Timokratis Karamitros, Kai Kisand, Ourania Koltsida, Cheng‐Lung Ku, Yu-Lung Lau, Yun Ling, C. Lucas, Tom Maniatis, Davood Mansouri, László Maródi, Isabelle Meyts, Joshua D. Milner, Kristina Mironska, Trine H. Mogensen, Tomohiro Morio, Lisa F. P. Ng, Luigi D. Notarangelo, Antonio Novelli, Giuseppe Novelli, Cliona O’Farrelly, Satoshi Okada, Keisuke Okamoto, Tayfun Özçelık, Qiang Pan‐Hammarström, Jean W. Pape, Rebeca Pérez de Diego, David S. Perlin, Graziano Pesole, Anna M. Planas, Carolina Prando, Aurora Pujol, Lluis Quintana-Murci, Sathishkumar Ramaswamy, Vasiliki Rapti, Laurent Rénia and 144 more - The Journal of Experimental Medicine 2022 cited by 128

  8. Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p

    Authors: , , , , , , , , , , - Cell Death and Disease 2019 cited by 350

  9. Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression

    Authors: , , , , , , , , , , , , , , , , , - Molecular Cancer 2020 cited by 273

  10. Gas‐Permeable, Multifunctional On‐Skin Electronics Based on Laser‐Induced Porous Graphene and Sugar‐Templated Elastomer Sponges

    Authors: , , , , , , , - Advanced Materials 2018 cited by 379

  11. Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zhigang Song, Xiaokui Guo, Li‐Kuang Chen, Tongyu Zhu - Emerging Microbes & Infections 2021 cited by 156

  12. Wearable sensor-based gait analysis to discriminate early Parkinson’s disease from essential tremor

    Authors: , , , , , , , - Journal of Neurology 2023 cited by 68

  13. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine M. Biggs, Dusan Bogunovic, Alexandre Bolze, Анастасія Бондаренко, Ahmed Aziz Bousfiha, Şefika Elmas Bozdemir, Petter Brodin, Yenan T. Bryceson, Carlos D. Bustamante, Manish J. Butte, Giorgio Casari, John Christodoulou, Roger Colobrán, Antônio Condino‐Neto, Stefan N. Constantinescu, Megan A. Cooper, Clifton L. Dalgard, Murkesh Desai, Beth A. Drolet, Jamila El Baghdadi, Melike Emiroğlu, Emine Hafize Erdeniz, Sara Elva Espinosa‐Padilla, Jacques Fellay, Carlos Flores, José Luis Franco, Antoine Froidure, Peter K. Gregersen, Bodo Grimbacher, Belgi̇n Gülhan, Filomeen Haerynck, David Hagin, Rabih Halwani, Lennart Hammarström, James R. Heath, Sarah E. Henrickson, Elena W.Y. Hsieh, Eystein S. Husebye, Kohsuke Imai, Yuval Itan, Petr Jabandžiev, Erich D. Jarvis, Timokratis Karamitros, Adem Karbuz, Kai Kisand, Cheng‐Lung Ku, YL Lau, Yun Ling, C. Lucas, Tom Maniatis, Davood Mansouri, László Maródi, Ayşe Metìn, Isabelle Meyts, Joshua D. Milner, Kristina Mironska, Trine H. Mogensen, Tomohiro Morio, Lisa F. P. Ng, Luigi D. Notarangelo, Antonio Novelli, Giuseppe Novelli, Cliona O’Farrelly, Satoshi Okada, Keisuke Okamoto, Şadiye Kübra Tüter Öz, Tayfun Özçelık, Qiang Pan‐Hammarström, Maria Papadaki, Jean W. Pape and 74 more - The Journal of Experimental Medicine 2022 cited by 115

  14. circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer

    Authors: , , , , , , , , , , , , , , , , , - Molecular Cancer 2022 cited by 92

  15. Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2024 cited by 85

  16. Viral and host factors related to the clinical outcome of COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 1,005

  17. Blood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The EMBO Journal 2020 cited by 187

  18. Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ren Zhao, Djillali Annane, Jieming Qu, Dechang Chen - The Lancet Regional Health - Western Pacific 2023 cited by 112

  19. The relationship between individual characteristics and experienced presence

    Authors: , , , , - Computers in Human Behavior, Comput. Hum. Behav. 2013 cited by 134

  20. Intrusion Detection in Cyber-Physical Systems: Techniques and Challenges

    Authors: , , , - IEEE Systems Journal, IEEE Syst. J. 2014 cited by 201

  21. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Lin, Yun Ling, Haofei Liu, Jianwei Liu, Nianping Liu, Shu‐Qiang Liu, Meng Luo, Qiang Ma, Song Qibing, Wujianan Sun, Gaoxiang Wang, Feng Wang, Ying Wang, Xiaofeng Wen, Qian Wu, Gang Xu, Xiaowei Xie, Xinxin Xiong, Xudong Xing, Hao Xu, Chonghai Yin, Dongdong Yu, Kezhuo Yu, Jinbo Yuan, Biao Zhang, Peipei Zhang, Tong Zhang, Jincun Zhao, Peidong Zhao, Peidong Zhao, Wei Zhou, Wei Zhou, Xiaosong Zhong, Shuye Zhang, Shuye Zhang, Ping Zhu, Bin Zou, Jiahua Zou, Jiahua Zou, Zengtao Zuo, Fan Bai, Xi Huang, Penghui Zhou, Qinghua Jiang, Zhiwei Huang, Lai Wei, Lai Wei, Xiu-Wu Bian, Xindong Liu, Tao Cheng, Xiangpan Li, Pingsen Zhao, Pingsen Zhao, Fang Wang, H Wang, Kun Qu, Zheng Zhang, Kun Qu, Xiaoqun Wang, Jiekai Chen, Ronghua Jin, Zemin Zhang - Cell 2021 cited by 194

  22. Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wei Li, Quanhong Wang, Xicheng Wang, Yichun Bai, Xiangao Jiang, Juan Ma, Bingying Xie, Kui Zhang, Lanjuan Li - The Lancet Infectious Diseases 2023 cited by 47

  23. A Meta-Analysis on the Relationship between Self-Reported Presence and Anxiety in Virtual Reality Exposure Therapy for Anxiety Disorders

    Authors: , , , , - PLoS ONE 2014 cited by 210

  24. Studying severe long COVID to understand post-infectious disorders beyond COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan N. Constantinescu, Megan A. Cooper, Clifton L. Dalgard, Murkesh Desai, Beth A. Drolet, Jamila El Baghdadi, Sara Elva Espinosa‐Padilla, Jacques Fellay, Carlos Flores, José Luis Franco, Antoine Froidure, Peter K. Gregersen, Bodo Grimbacher, Filomeen Haerynck, David Hagin, Rabih Halwani, Lennart Hammarström, James R. Heath, Sarah E. Henrickson, Elena W.Y. Hsieh, Eystein S. Husebye, Kohsuke Imai, Yuval Itan, Erich D. Jarvis, Timokratis Karamitros, Kai Kisand, Cheng‐Lung Ku, YL Lau, Yun Ling, C. Lucas, Tom Maniatis, Davood Mansouri, László Maródi, Isabelle Meyts, Joshua D. Milner, Kristina Mironska, Tomohiro Morio, Lisa F. P. Ng, Antonio Novelli, Giuseppe Novelli, Satoshi Okada, Keisuke Okamoto, Tayfun Özçelık, Qiang Pan‐Hammarström, Jean W. Pape, Rebeca Pérez de Diego, David S. Perlin, Graziano Pesole, Anna M. Planas, Carolina Prando, Aurora Pujol, Lluís Quintana‐Murci, Sathishkumar Ramaswamy, Laurent Rénia, Igor Resnick, Carlos Rodríguez‐Gallego, Vanessa Sancho‐Shimizu, Anna Šedivá, Mikko Seppänen, Mohammed Shahrooei, Anna Shcherbina, Ondřej Slabý, Andrew L. Snow, Pere Soler‐Palacín, András N. Spaan, Stuart G. Tangye, Ahmad Abou Tayoun, Stuart E. Turvey, K. M. Furkan Uddin, Mohammed Uddin and 7 more - Nature Medicine 2022 cited by 144